Introduction
Astrocytic tumors are the most common form of primary brain tumors and their histological classification ranges from low grade astrocytomas to glioblastoma multiforme (GBM), the end-stage and most malignant form of the disease. A number of chromosomal abnormalities are observed during the formation of GBM including ampli®cations of chromosome 7, speci®cally the EGF-R gene, and deletions of chromosomes 9p, 10p, 10q, 11p, 13, 17p and 22 (Wong et al., 1987; James et al., 1988; Bigner et al., 1990; Fults et al., 1992; Rasheed et al., 1992 Rasheed et al., , 1995 Ransom et al., 1992; Steck et al., 1995) . Although candidate genes corresponding to some of these genetic losses have been identi®ed (Fults et al., 1989; James et al., 1989; Kamb et al., 1994; Henson et al., 1994) , the speci®c genes mapping to the remaining loci remain elusive. For instance, loss of heterozygosity on chromosome 11 has been shown to occur in 30 ± 40% of astrocytic tumors, yet no gene has been identi®ed as the target of this loss (Fults et al., 1992; Sonoda et al., 1995) . By far the most frequent cytogenetic and molecular abnormality observed in GBM is the deletion of large regions of chromosome 10, however no speci®c region critical to the development of GBM has been identi®ed on this chromosome (Bigner et al., 1988; James et al., 1988; Ransom et al., 1992; Karlbom et al., 1993) . The eorts to de®ne a critical interval have been hindered by the fact that the loss of large regions or an entire copy of the chromosome occurs in 70 ± 95% of these tumors. Consequently a minimally deleted region has been dicult to delineate (Rasheed et al., 1992 (Rasheed et al., , 1995 Ransom et al., 1992) .
Subtractive hybridization is one attractive approach used to de®ne genes that are dierentially expressed between normal and tumor cells, because it does not require knowledge of the genomic location of target genes. This technique has been used previously to study dierential expression in many tumor systems and to identify candidate genes involved in the suppression of tumorigenesis (Dowdy et al., 1991; Lee et al., 1991; Hutchins et al., 1991; Schweinfest et al., 1993; Murphy et al., 1993) . To address the functional signi®cance of the loss of chromosome 10 in GBM, suppressed hybrid cells were previously created by transferring a chromosome 10 into recipient GBM cells (Pershouse et al., 1993; Ligon et al., submitted) . The resulting hybrid cells and their tumorigenic counterparts were then used to perform a cDNA/mRNA subtractive hybridization. A number of cDNAs were identi®ed through this subtraction, including several whose expression suggested that the presence of an intact, functioning chromosome 10 may have in¯uenced the dierentiation status of glioma cells (Ligon et al., submitted) . In this paper we describe the isolation, characterization and mapping of a novel subtracted cDNA (clone 17) whose expression was coincident with the nontumorigenic phenotype.
Results

Identi®cation of a novel cDNA
We used the clone 17 cDNA isolated by subtractive hybridization to probe a fetal brain cDNA library and identify 32 clones (Ligon et al., submitted) . One cDNA in particular was selected because it closely approximated the message size (2.6 kb) previously detected by Northern analysis with clone 17, and because this longer cDNA (RIG, regulated in glioma) was found to contain clone 17 in its entirety. Subsequently, Northern analysis using RIG demonstrated a dierential expression pattern identical to that of clone 17 in suppressed hybrid cells and their tumorigenic counterparts ( Figure  1a) . Speci®cally, RIG was expressed four to 10-fold more in nontumorigenic hybrid cells than in GBM cells. A panel of human adult tissues was studied for RIG expression and highest mRNA levels were observed in brain, with lower levels detectable in heart and lung (Figure 1b) . Placenta, skeletal muscle, kidney, pancreas and liver showed no expression even upon extended exposure of the Northern blot. In addition to RIG, ®ve other clones (1.7 ± 2.8 kb) were also identi®ed by this screening and were found to be related by partial sequence homology with the original clone 17. However, RIG was the only cDNA that contained the entire clone 17 sequence, indicating that clone 17 likely represented a fragment of RIG, and not of any of the related clones. This homology, however, was not the sole reason for the similar expression patterns observed for clone 17 and RIG since identical results were obtained even when clone 17 was removed from RIG by enzymatic digestion prior to Northern analysis.
Sequence analysis de®ned a 2569 bp RIG cDNA ( Figure 2 ) and was con®rmed by analysing three additional RIG cDNAs from independent nontumorigenic specimens. No nucleic acid homologies to any known genes were detected following searches of the relevant databases (EMBL, Genbank) using the BLAST program (Altschul et al., 1990) . However, a 98% homology was detected between RIG and a 286 bp anonymous expressed sequence tag (EST IB666; Khan et al., 1992) . More recently, this homology was extended to include several related ESTs (EST56233, 59369, 48217 and 59418), all previously isolated from fetal brain libraries.
Sequencing of the RIG cDNA did not identify either a poly(A) + tail or consensus sequence, so sense and antisense riboprobes were generated and hybridized against Northern blots to determine the correct cDNA orientation (data not shown). This analysis identi®ed the coding strand and oriented the cDNA such that the IB666 sequence appeared in the 3'-untranslated region (Figure 2 ). Both 5' and 3' rapid ampli®cation of cDNA (RACE) were performed to determine whether the RIG cDNA sequence was complete, but neither analysis identi®ed any additional sequence. However, since the RIG cDNA already approximated the message size determined by Northern analysis, this suggested that the clone was essentially full length.
An examination of seventeen cultured glioma cell lines or primary glioma cell cultures identi®ed ®ve glioma cell lines that showed no RIG expression at all (D54, D77, U343, U87, U138). The majority of other cultured gliomas examined showed low levels of RIG message (Figure 3 ). This pattern of absent (or reduced) expression in the tumorigenic GBM cells was relative to message levels seen in cultured nonneoplastic fetal brain cells and human astrocytes (FB138, 13-week astrocytes) and was also similar to levels observed in chromosome 10-containing hybrid cells. However, three cell lines (PH-2, EFC-2 and U118) showed levels of RIG expression approximating that of the normal cells. It is worth noting that PH-2 cells were derived from an ependymoma in which alteration of chromosome 10 has not been detected and is not a common event. Similarly, U118 was derived from a mixed tumor with ependymomal and anaplastic astrocytoma components for which the status of chromosome 10 is unknown. The signi®cance of increased RIG in EFC-2 cells is unclear, but may be related to genomic alteration at the RIG locus. Furthermore, no RIG mRNA could be detected in four neuroblastoma and three medulloblastoma-derived cell lines, suggesting that RIG expression may be restricted to cells of glial lineage.
To test for any biological signi®cance for preferential expression of RIG, a series of brain tumor
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LG11.S3 Tissue distribution of RIG expression is identical to that observed for clone 17. This blot shows increased loading of mRNA in the heart lane relative to brain and lung, yet both tissues showed less RIG expression than brain (0.46in heart and 0.36 in lung, relative to brain levels). No message was detected in placenta, liver, skeletal muscle, kidney or pancreas. Signal intensities were quantitated based on control hybridization to b-actin (not shown) specimens was examined by RT-PCR analysis ( Figure  4 ). A signi®cant decrease in RIG message was found in malignant GBM tumors compared to the levels observed in normal brain and in low-grade astrocytomas. Two GBM derived specimens did show increased expression of RIG, however, study of adjacent histological sections of these samples revealed the presence of normal cells, which are a likely source of increased RIG message. These results demonstrate that decreased expression of RIG is not restricted to cultured GBM cells but is also evidenced in tumor specimens.
Genomic structure of RIG
We examined the genomic structure of RIG in cultured glioma cell lines, normal astrocytic cells and tumor specimens. In the majority of samples examined, no genomic alterations of RIG were detectable. However, LG11
LG11 Figure 4 RT ± PCR analysis of RIG expression of cDNA synthesized from frozen sections of normal brain, low grade astrocytomas, and glioblastomas. (a) The expression of RIG and GAPDH following RT ± PCR. The mRNA was treated with DNAse prior to cDNA synthesis to remove contaminating genomic DNA. (b) The quantitation of PCR products were determined by densitometry and compared to GAPDH expression. The horizontal bar represents the mean of the determined ratio of RIG/GAPDH expression in three cultured GBM cell lines (U87, U138 and EFC-2) genomic alterations were detected following HindIII or EcoRI digests ( Figure 5 ). The rearrangements identi®ed in EFC-2 cells are notable because these cells consistently demonstrated increased expression of RIG which may be, in part, due to the gross changes in gene structure. In contrast, U87 cells express no RIG mRNA at all, while U138 cells express barely detectable quantities of RIG. Southern blot analyses were also used to determine that RIG is a relatively small gene, less than 5.1 kb in size. Furthermore, polymerase chain reaction (PCR) primers designed to amplify the predicted open reading frame ampli®ed the same sized products whether cDNA or genomic DNA was used as a template, suggesting that RIG consists of a single coding exon (data not shown).
Predicted protein product of RIG
We identi®ed a likely, though small (285 bp), open reading frame for RIG beginning at position 531 (see Figure 2 ). Evidence to support this codon as the correct site of initiation was obtained using coupled in vitro transcription and translation (TNT). This assay demonstrated that the RIG cDNA can direct the synthesis of an approximately 12 kD protein ( Figure  6 ), in agreement with the predicted size (11.5 kD). In order to con®rm this codon as the correct initiation site, we cloned the RIG cDNA into two independent vectors and then tested each construct in both the sense and antisense directions. The predicted protein (11.5 kD) could be identi®ed in both the`sense' TNT reactions but not with either of the`antisense' reactions. As seen in Figure 6 , a larger protein product (approximately 25 kD) was also identi®ed when the TNT reaction was performed using the sense orientation of the RIG-pGEM construct. Since the size of this product could not be attributed to any reading frames within RIG, we examined the surrounding sequence and found an in-frame initiation codon within the multicloning site of the pGEM vector. Initiation of translation from this site would result in a 25 kD product. Indeed, this resulting fusion product was not detected in any of the TNT reactions that were performed using the RIG-Bluescript construct and can therefore be considered artifactual.
Amino acid sequence analysis of the predicted RIG protein using the BLASTp search program (including protein databases such as SWISS-PROT, Brookhaven Protein Data Bank, PIR and GenPept.) did not identify homology to any known proteins. The amino acid content was noted to be rich in arginine, threonine, and leucine residues. Two-dimensional electrophoresis of the TNT protein product con®rmed the synthesis of a protein product with a relatively high pI.
Genomic mapping of RIG
A combination of somatic cell hybrid mapping and uorescence in situ hybridization was used to map the genomic location of RIG. Hybridization of RIG to a somatic cell mapping panel of HindIII digested DNA showed two predominant bands of 2.0 and 2.5 kb only in DNA that contained human chromosome 11, thereby mapping RIG to this chromosome. Furthermore, a 3.2 kb band was observed in hamster DNA and a single 6.6 kb band in mouse DNA, indicating evolutionary conservation of the RIG gene amongst these rodents.
The RIG cDNA was used to screen a P1 library and one of the identi®ed genomic clones was used as a probe for¯uorescence in situ hybridization (FISH) of metaphase chromosomes. Positive signals were seen on the short arm of a pair of C group chromosomes with a fractional telomeric length (FTL) of 0.12+0.02 (Figure 7a ). FISH was repeated on G-banded chromosomes and identi®ed the target as chromosome 11 and also allowed us to map the RIG gene to 11p15.1 (data not shown). We also performed FISH using metaphases prepared from U87 cells that observed only one signal on an apparently normal chromosome 11. The second signal was observed on a marker chromosome, illustrating a gross rearrangement of the 11p region. Although FISH results suggest that the RIG allele on this marker chromosome may not be aected, our southern analysis has demonstrated genomic rearrangements of RIG in these cells. 
Discussion
The role of tumor suppressor genes in oncogenesis has been well documented (Weinberg, 1991; Marshall, 1991; Stanbridge, 1992) . Clearly, loss of speci®c genes or even entire chromosomes are only two methods by which the negative regulatory function of these genes may be compromised. Here we describe a novel cDNA (RIG), isolated through subtractive hybridization, which appears to be involved in, or act as a marker of, malignant GBM formation. RIG was initially identi®ed as one of several genes which exhibited a dierential expression between tumorigenic and suppressed GBM cells. This gene product was chosen for further analysis based on its expression predominantly in the brain and its large degree of preferential expression pattern.
Searches of relevant databases showed RIG to be a novel gene product whose only homology was to an anonymous EST previously cloned from an infant brain cDNA library (Khan et al., 1992) . The abundance of this message in fetal brain was low, estimated to be 0.004% based on the frequency with which clones were isolated during the fetal brain library screening, although there is apparently increased expression in adult brain. A striking feature of RIG was its consistent preferential expression in normal human brain relative to gliomas. Signi®cant levels of RIG message were observed in both cultured astrocytes and in normal adult brain. In contrast, decreased RIG expression was found in cultured GBM cells and primary GBM specimens compared to that of normal glia. Examination of a number of primary glioma samples (n=17) demonstrated signi®cantly decreased levels of RIG mRNA, with ®ve samples (30%) showing a complete lack of expression. Gliomas of histologic lower grade showed an expression level similar to normal brain suggesting that decreased expression of RIG may be correlated with the functional status of a glioma tumor suppressor gene(s) on chromosome 10. Deletions of chromosome 10 are predominantly associated with the malignant progression of GBM (James et al., 1988) . Also supporting this possibility is the fact that RIG was originally isolated based on hybrid glioma cells containing a functional copy of chromosome 10 (Ligon et al., submitted). Furthermore, two cell lines derived from a low-grade astrocytoma and an ependymoma, both tumor types with no known alterations of chromosome 10, showed similarly high levels of RIG mRNA. Therefore, in this study, RIG expression is correlated with the presence of functional tumor suppressive genes on chromosome 10. Since the identity of the suppressive gene(s) on chromosome 10 is currently unknown, RIG may represent the ®rst molecular marker to re¯ect the status of a glioma tumor suppressor gene.
The genomic location (11p15.1) and observed alterations to this locus raise some interesting possibilities for RIG involvement in oncogenesis. Loss of heterozygosity studies have previously implicated chromosome 11p15 in the genesis of multiple cancers, including Wilms tumor, small cell lung carcinoma, non-small cell lung carcinoma, bladder carcinoma, breast carcinoma and astrocytoma (Fults et al., 1992; Sonoda et al., 1995; Weston et al, 1989; Ludwig et al., 1991; Hao et al., 1993; Wingvist et al., 1993) . Since most allelic deletion studies of astrocytomas have implicated the region 11p15.5 and not 11p15.1, it appears unlikely that RIG would be deleted in astrocytomas. However, allelic deletions around 11p15.1 were not investigated in most studies (Fults et al., 1992; Sonoda et al., 1995) . We identi®ed structural alterations of RIG in three cultured GBM cell lines. These rearrangements are notable because one GBM-derived cell line (EFC-2) was shown to express RIG at a level comparable to`normal' cells, whereas the remaining two cell lines show very low or undetectable levels of RIG message. Together these data suggest a possible scenario in which RIG may act downstream of the 10q glioma tumor suppressor gene. Further studies are required to determine whether structural changes in RIG (or in associated cis elements) contribute to its preferential expression in low grade tumors, and to de®ne the biological mechanism(s) through which RIG acts.
Transcription and translation studies con®rmed that, at least in vitro, RIG can direct the synthesis of the predicted 11.5 kD protein product. The highly basic nature of this protein allows for speculation regarding a possible interaction between a RIG protein and negatively charged molecules, perhaps including DNA. Alternatively, as no known protein motifs were detected in the amino acid sequence, the gene product of RIG may not be a protein, but rather an RNA molecule itself. Precedence for this can be found in studies of the H19 RNA, an RNA that has been suggested to act as a tumor suppressor in vitro and coincidentally also maps near RIG at 11p15.5 (Brannan et al., 1990; Jaber et al., 1994) .
The identi®cation of a set of cDNAs related to RIG by partial sequence homology is intriguing. Thus far, ®ve independent clones have been identi®ed sharing a partial homology with clone 17. The IB666 sequence (90 ± 130 bp) appears to be con®ned to the 3' untranslated region of the messages, and the possibility that this may represent a functional ciselement is presently under study. The further characterization of this novel family of genes may aid in our understanding of the oncogenesis of brain tumors, however, the expression of RIG should serve to re¯ect the status of a chromosome 10 tumor suppressor gene.
Materials and methods
Tissues and cells
The generation and culture of the somatic cell hybrids have been previously described (Pershouse et al., 1993; Ligon et al., submitted) . The glioma cell cultures have been established in our laboratory either from glioma specimens or were obtained from ATCC (Yung et al., 1988) . Glioma specimens were kindly provided and examined by Dr L Langford, Department of Pathology, UTMADCC.
DNA analysis
A human fetal brain expression library was obtained from Stratagene (La Jolla, CA) and screened with a radioactively labeled clone 17 cDNA. Labeling of the isolated insert was performed with [a 32 P]dCTP using the random primed method (Feinberg and Vogelstein, 1984) . Positive plaques were puri®ed in three rounds of screening and the inserts were obtained by PCR following the procedures previously described (Ligon et al., submitted). The inserts were cloned into the pCRII vector using the TA cloning kit (InVitrogen, San Diego, CA). Southern blot analysis was performed using DNA isolated from cell cultures or tumor specimens according to standard laboratory procedures (Sambrook et al, 1989) . The DNA was transferred to Hybond N + membranes (Amersham, Chicago, IL), u.v. cross-linked according to manufacturer's protocols and hybridized.
For sequencing, the cDNA insert was cloned into the EcoRV site of the pGEM5zf(7) vector (Promega, Madison, WI) before creating the deletion constructs. An array of inserts representing nested deletions spanning the RIG cDNA was then selected for sequencing using the T7 primer. A total of 15 overlapping inserts, each successively deleted by approximately 150 ± 200 bp, was sequenced to obtain the full-length sequence of RIG. The sequence of the complementary strand was con®rmed using both primer walking and automated sequencing.
Rapid ampli®cation of cDNA ends (RACE) was performed in both directions (Frohman et al., 1988) . For 3' RACE, the following primers were synthesized: internal primers 5'-gggaaaagaaatccaagaact-3' or 5'-gcatgcttatacaatcatgtg-3' and oligo(dt) primer 5'-gactcgagtcgacatcgattttttttttttttttt-3'. The 5' AmpliFINDER RACE kit (Clontech, Palo, Alto, CA) was used to perform 5' RACE.
RNA analysis
Poly(A) + mRNA was isolated using Fast Track mRNA isolation kit (InVitrogen) from cells or from fresh frozen sections of human gliomas. mRNA (3 mg) was electrophoresed in formaldehyde gels, blotted onto Hybond N + membranes, and then hybridized (Sambrook et al., 1989) . Alternatively, mRNA was treated with DNAse and used to synthesize cDNA with oligo dT primers and Superscript reverse transcriptase (GIBCO). Quantitative comparisons of RNAs were made by densitometric comparison to glyceraldehyde-3-phosphate dehydrogenase hybridization or (for PCR analysis) using primers speci®c for glyceraldehyde-3-phosphate.
An in vitro transcription kit (Promega) was used to synthesize riboprobes. Riboprobes were generated from the sense and antisense directions of the RIG cDNA to ascertain the orientation by northern analysis. Hybridization with the appropriate sense or antisense riboprobe was performed according to the manufacturer's instructions.
In vitro transcription and translation
The coupled TNT rabbit reticulocyte lysate system (Promega) was used to synthesize the RIG peptide product. RIG cDNA was ®rst subcloned independently into two plasmid vectors, pBluescript SK 7 (Stratagene) and pGEM5f(z) (Promega), and each construct was used to generate both sense and antisense transcripts from RIG cDNA. Translated reactions were then electrophoresed on a 5 ± 15% gradient SDS-polyacrylamide gel, followed bȳ uorography and exposure to X-ray ®lm.
Chromosomal localization
A commercially produced somatic cell hybrid mapping panel consisting of various mouse-human and hamsterhuman hybrids was obtained from BIOS (New Haven, CT). Southern blot analysis was performed with 32 P-labeled cDNA probes (RIG, clone 17). Fluorescence in situ hybridization was performed with a P1 clone obtained commercially by screening a P1 library with the RIG cDNA (BIOS P1 #1488). The P1 clone was biotinylated using nick-translations then hybridized with normal human lymphocyte metaphases. Slides were washed and detected with avidin-¯uorescein isothiocyanate and ampli®ed with anti-avidin as previously described (Steck et al., 1995; Pershouse et al., 1993) .
